Modex Therapeutics, An Opko Health Company

This early-stage study is testing an experimental drug called MDX2004 in people with advanced cancers that have spread or cannot be removed by surgery. The main goals are to find a safe dose, check for side effects, and see if the drug can shrink tumors. It will enroll about 235 …

This early-stage study is testing an experimental drug called MDX2003 for people with several types of B-cell lymphoma that have come back or stopped responding to at least two prior treatments. The main goals are to find a safe dose and see if the drug can shrink tumors. It will…

This is an early-stage study testing a new drug called MDX2301 to see if it can help prevent severe COVID-19. Researchers will give single and repeat injections to 80 healthy adults and adults with conditions that put them at higher risk for severe COVID-19. The main goal is to c…